# Precision Cardiovascular

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/precision-cardiovascular

- Industry: Healthcare
- Headquarters: Uxbridge, UK
- Website: www.precision-cv.com
- Total disclosed funding: $0.8M
- Latest round: Seed (May 21, 2023)
- Investors on record: 1

## About

Based in London, UK, and founded in 2021 by CEO Mohamed Abou-Alam and COO David Hampton, Precision Cardiovascular Ltd. operates as a medical-based company developing and manufacturing micro-sensors for patients to deduction of cardiovascular complications. In May 2023, Precision Cardiovascular Ltd. raised USD 0.75 million in seed funding from Acasia, with participation from the company's management.  

Precision Cardiovascular Ltd. developed a platform that provides reports and information-based summaries from complex data for healthcare interventions and predictive assessments of the heart. The company manufactured sensors that allow users to measure information related to patients’ heart health from their homes, providing individual insights to personalize treatment. In addition, the firm offers clinicians driven to assess chronic conditions and prevent their progression. Precision Cardiovascular Ltd. uses artificial intelligence to implement an online health system for the remote management of cardiovascular diseases.

## Funding rounds

- Seed, May 21, 2023, $0.8M — Acasia

## Investors

- Acasia (https://capitalatlas.ai/funds/acasia) — Seed